一些主要投资者增加了在AstraZeneca的股权。 AstraZeneca报告收入丰厚,市场上限为2 167.2亿美元。 Several major investors increased their stakes in AstraZeneca, which reported strong earnings and has a market cap of $216.72 billion.

几个机构投资者在第一季度增加了其在AstraZeneca PLC的股份。 Several institutional investors boosted their holdings in AstraZeneca PLC during the first quarter. Canandaigua国家银行、Smith Salley财富管理公司和Cidel资产管理公司的股份分别增加了11.6%、3.8%和46 033股。 Canandaigua National Bank, Smith Salley Wealth Management, and Cidel Asset Management increased their shares by 11.6%, 3.8%, and added 46,033 shares respectively. AstraZeneca报告收入丰厚,估计收入丰厚,EPS为124美元,市场上限为2 167.2亿美元。 AstraZeneca reported strong earnings, beating estimates with $1.24 EPS, and has a market cap of $216.72 billion. 该股票的评级是“移动买家”,平均价格目标为85.00美元。 The stock has a "Moderate Buy" rating with an average price target of $85.00.